The month of July brought in U.S. patent protection for nine Vanderbilt University technologies, ranging in scope from mass spectrometry to drug development. The technologies earning patent protection are:
|
|
Methods of using an antibody to inhibit WNT-mediated cardiac remodeling |
|
|
|
Surface structures for enhancement of quantum yield in broad spectrum emission nanocrystals |
|
|
|
MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
|
|
|
Methods and apparatuses for analyzing biological samples by mass spectrometry |
|
|
|
Indole compounds as positive allosteric modulators of the muscarinic receptor |
|
|
|
Use of GSK3 inhibitors in combination with radiation therapies |
|
|
|
Microstereotactic table |
|
|
|
Apparatus and methods of compensating for organ deformation, registration of internal structures to images, and applications of same |
|
|
|
Ligands to radiation-induced molecules |